High-Dose Betahistine Improves Cognitive Function in Patients With Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

Background: There is currently no effective treatment for cognitive impairment associated with schizophrenia (CIAS). Recent studies have shown that increased histamine levels in the brain may help to improve CIAS symptoms. Betahistine is an H1-receptor agonist and H3-receptor antagonist. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yongqian, Huang, Xufeng, Fan, Hongzhen, An, Huimei, Ma, Ting, Zhang, Qi, Zhao, Wenxuan, Yun, Yajun, Yang, Wenshuang, Zhang, Xiaolu, Wang, Zhiren, Yang, Fude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591287/
https://www.ncbi.nlm.nih.gov/pubmed/34790138
http://dx.doi.org/10.3389/fpsyt.2021.762656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591287/
https://www.ncbi.nlm.nih.gov/pubmed/34790138
http://dx.doi.org/10.3389/fpsyt.2021.762656

Ejemplares similares